Buspirone hydrochloride
NDC 50268-135, Buspirone hydrochloride, tablet, from AvPAK.
- Product NDC
- 50268-135
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078888
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUSPIRONE HYDROCHLORIDE15 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-135-15 | 50268013515 | 50 BLISTER PACK in 1 BOX (50268-135-15) / 1 TABLET in 1 BLISTER PACK (50268-135-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b230197c-3d50-7874-e053-2a95a90af50fNADAC price for package 50268013515
GET /v1/drugs/nadac/50268013515
Use it
Look up 50268-135 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.